Persistent Mixed Donor Chimerism following Double Umbilical Cord Transplantation in a Patient with T-Cell Prolymphocytic Leukemia
Autor: | James K. Mangan, Elizabeth O. Hexner, Ronak Mistry |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
Umbilical Cord Blood Transplantation business.industry lcsh:RC633-647.5 Case Report General Medicine lcsh:Diseases of the blood and blood-forming organs medicine.disease Umbilical cord Surgery Transplantation 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure 030220 oncology & carcinogenesis medicine Alemtuzumab T-cell prolymphocytic leukemia Pentostatin Stem cell Prolymphocytic leukemia business 030215 immunology medicine.drug |
Zdroj: | Case Reports in Hematology, Vol 2019 (2019) Case Reports in Hematology |
ISSN: | 2090-6579 2090-6560 |
Popis: | T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive postthymic T-cell neoplasm with an associated survival time of 1 year when left untreated. Current standard of care for T-PLL is with alemtuzumab, followed by allogeneic or autologous stem cell transplant. Little is found in the literature about alternative donor transplantation in T-PLL. Here, we present the case of a patient treated with double umbilical cord blood transplantation, which resulted in initial complete remission. An unusual outcome of this case is that coengraftment of both cords was established. After 16 months, the patient had relapse of the disease, unfortunately, prompting treatment with alemtuzumab and pentostatin, which resulted in remission once again. Here, we report a unique phenomenon whereby single-cord dominance occurred after treatment with these agents, suggesting that anti-T-cell therapy after transplant may help achieve single-unit dominance. A second relapse of the disease occurred six months thereafter, ultimately resulting in the patient’s death, highlighting the aggressive nature of this disease. |
Databáze: | OpenAIRE |
Externí odkaz: |